不同强度华法林抗凝对老年非瓣膜性房颤患者长期疗效及预后的影响

Long-term efficacy and prognosis of warfarin anticoagulation at different intensities in elderly patients with non-valvular atrial fibrillation

  • 摘要:
      目的  探讨老年非瓣膜性房颤患者采用不同强度华法林抗凝治疗对预后及长期疗效的影响。
      方法  选取90例老年非瓣膜性房颤患者,结合华法林抗凝治疗强度分为低强度组、标准强度组与阿司匹林治疗组,各30例。低强度组的国际标准化比率(INR)为1.6~2.0, 标准强度组的INR为2.1~3.0。经3、6、12、24个月治疗后,对比3组患者肾脏功能的改善效果以及血栓栓塞、出血、终点事件的发生情况。
      结果  治疗前及治疗3个月后, 3组间肌酐清除率(Ccr)水平无显著差异(P>0.05); 治疗3个月后, 3组患者的Ccr水平均显著升高(P < 0.05); 经6、12、24个月治疗后,低强度组与标准强度组患者的Ccr较治疗前显著提高(P < 0.05), 阿司匹林组Ccr则较治疗前显著降低(P < 0.05), 且与低强度组、标准强度组差异显著(P < 0.05)。治疗后,低强度组患者与标准强度组患者血栓栓塞发生率显著低于阿司匹林组(P < 0.05); 低强度组患者终点事件发生率显著低于阿司匹林组(P < 0.05), 但与标准强度组相较无显著差异(P>0.05)。
      结论  在老年非瓣膜性房颤患者的治疗过程中采取低强度华法林抗凝治疗,可显著改善患者的肾脏功能,降低出血发生率,用药安全性更高。

     

    Abstract:
      Objective  To study the effect of warfarin anticoagulation therapy in different intensity on prognosis and long-term efficacy in elderly patients with non-valvular atrial fibrillation.
      Methods  A total of 90 elderly patients with non-valvular atrial fibrillation admitted to our hospital were divided into low intensity group, standard intensity group and aspirin treatment group according to the intensity of warfarin anticoagulation therapy, with 30 cases in each group. International standardized ratio(INR) of low intensity group was 1.6~2.0, and 2.1~3.0 in standard intensity group. After 3, 6, 12, and 24 months of treatment, the improvement of renal function and the occurrence of thromboembolism, hemorrhage, and endpoint events were compared between the three groups.
      Results  There was no significant difference in creatinine clearance (Ccr) among the three groups after 3 months of treatment compared with before treatment (P>0.05). Ccr levels of of the three groups were improved after 3-month treatment(P < 0.05). After 6, 12 and 24 months of treatment, the Ccr levels of the low intensity group and the standard intensity group were significantly higher(P < 0.05), and was decreased in aspirin group compared with treatment before(P < 0.05), and significant differences were observed in low intensity group, and standard intensity group(P < 0.05). After treatment, the incidence of thromboembolism of the low intensity group and standard intensity group was significantly lower than that of aspirin group (P < 0.05). The incidence of endpoint events in low intensity group was significantly lower than that in aspirin group (P < 0.05), while there was no significant difference between standard intensity group and aspirin group (P>0.05).
      Conclusion  Low-intensity warfarin anticoagulation therapy can significantly improve renal function, reduce the incidence of bleeding and improve the safety of medication in the treatment of elderly patients with non-valvular atrial fibrillation.

     

/

返回文章
返回